Galapagos NV (GLPG)
27.13
+1.91
(+7.57%)
USD |
NASDAQ |
Nov 22, 16:00
27.12
-0.02
(-0.06%)
After-Hours: 20:00
Galapagos Enterprise Value: -1.941B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | -1.941B |
| November 21, 2024 | -2.067B |
| November 20, 2024 | -2.039B |
| November 19, 2024 | -1.970B |
| November 18, 2024 | -1.950B |
| November 15, 2024 | -1.963B |
| November 14, 2024 | -1.891B |
| November 13, 2024 | -1.913B |
| November 12, 2024 | -1.929B |
| November 11, 2024 | -1.885B |
| November 08, 2024 | -1.946B |
| November 07, 2024 | -1.920B |
| November 06, 2024 | -1.950B |
| November 05, 2024 | -1.967B |
| November 04, 2024 | -1.969B |
| November 01, 2024 | -1.957B |
| October 31, 2024 | -1.987B |
| October 30, 2024 | -1.845B |
| October 29, 2024 | -1.848B |
| October 28, 2024 | -1.834B |
| October 25, 2024 | -1.821B |
| October 24, 2024 | -1.790B |
| October 23, 2024 | -1.753B |
| October 22, 2024 | -1.736B |
| October 21, 2024 | -1.683B |
| Date | Value |
|---|---|
| October 18, 2024 | -1.702B |
| October 17, 2024 | -1.736B |
| October 16, 2024 | -1.780B |
| October 15, 2024 | -1.796B |
| October 14, 2024 | -1.800B |
| October 11, 2024 | -1.765B |
| October 10, 2024 | -1.803B |
| October 09, 2024 | -1.796B |
| October 08, 2024 | -1.769B |
| October 07, 2024 | -1.734B |
| October 04, 2024 | -1.806B |
| October 03, 2024 | -1.864B |
| October 02, 2024 | -1.860B |
| October 01, 2024 | -1.851B |
| September 30, 2024 | -1.832B |
| September 27, 2024 | -1.748B |
| September 26, 2024 | -1.738B |
| September 25, 2024 | -1.796B |
| September 24, 2024 | -1.776B |
| September 23, 2024 | -1.748B |
| September 20, 2024 | -1.713B |
| September 19, 2024 | -1.671B |
| September 18, 2024 | -1.682B |
| September 17, 2024 | -1.663B |
| September 16, 2024 | -1.656B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.571B
Minimum
Dec 03 2021
11.25B
Maximum
Feb 21 2020
-24.09M
Average
-1.470B
Median
Jul 12 2021
Enterprise Value Benchmarks
| UCB SA | 37.88B |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 241.66M |
| Celyad Oncology SA | -- |
| MDxHealth SA | 95.14M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -55.46M |
| Revenue (Quarterly) | 65.82M |
| Total Expenses (Quarterly) | 125.55M |
| EPS Diluted (Quarterly) | -0.8469 |
| Gross Profit Margin (Quarterly) | 99.97% |
| Profit Margin (Quarterly) | -84.26% |
| Earnings Yield | 12.41% |
| Normalized Earnings Yield | -3.745 |